论文部分内容阅读
目的观察低分子肝素治疗不稳定型心绞痛(UAP)的临床疗效。方法根据WHO的UAP的诊断标准,将60例UAP患者随机分为低分子肝素组(30例)和阿司匹林对照组(30例)进行治疗,观察两组对心绞痛的疗效。结果应用低分子肝素组心绞痛发作次数、持续时间、心电图变化均较对照组明显改善。结论应用低分子肝素治疗UAP疗效显著,能有效控制心绞痛发作,有效预防急性心肌梗死的发生。
Objective To observe the clinical effect of low molecular weight heparin in the treatment of unstable angina pectoris (UAP). Methods According to WHO diagnostic criteria of UAP, 60 UAP patients were randomly divided into low molecular weight heparin group (30 cases) and aspirin control group (30 cases). The curative effect of angina pectoris in both groups was observed. Results The application of low molecular weight heparin angina pectoris episodes, duration, ECG changes were significantly improved compared with the control group. Conclusion The application of low molecular weight heparin in the treatment of UAP has significant curative effect, which can effectively control angina pectoris and effectively prevent the occurrence of acute myocardial infarction.